Search

Julie Annita Villanueva

from Roswell, GA
Age ~52

Julie Villanueva Phones & Addresses

  • 220 Moonshadow Ct, Roswell, GA 30075
  • Cupertino, CA
  • San Jose, CA
  • Atlanta, GA
  • Cutler Bay, FL

Work

Company: People's united bank 2013 Position: Senior financial services associate

Education

School / High School: Kaplan University- Fort Lauderdale, FL 2010 Specialities: MBA in Marketing

Skills

Microsoft Word • Excel • PowerPoint • Outlook • PeopleSoft • Social Media Applications

Professional Records

License Records

Julie A Villanueva

Address:
220 Moonshadow Ct, Roswell, GA
Phone:
(678) 551-2457
License #:
9925 - Active
Category:
Health Care
Issued Date:
Jun 30, 1992
Effective Date:
Feb 12, 2010
Expiration Date:
Feb 28, 2018
Type:
Dental Hygienist

Resumes

Resumes

Julie Villanueva Photo 1

Julie Villanueva

Julie Villanueva Photo 2

Julie Villanueva

Julie Villanueva Photo 3

Julie Villanueva

Julie Villanueva Photo 4

Julie Villanueva

Julie Villanueva Photo 5

Julie Villanueva

Skills:
Microsoft Office
Microsoft Excel
Julie Villanueva Photo 6

Julie Villanueva

Julie Villanueva Photo 7

Julie Villanueva

Julie Villanueva Photo 8

Julie Villanueva

Publications

Us Patents

Compounds That Bind P2Yor P2Yreceptors

US Patent:
7056889, Jun 6, 2006
Filed:
Dec 16, 2002
Appl. No.:
10/320731
Inventors:
Julie M. Villanueva - Decatur GA, US
Stephen Quirk - Alpharetta GA, US
Assignee:
Kimberly-Clark, Worldwide, Inc. - Neenah WI
International Classification:
A61K 31/00
A61K 38/00
A61K 38/05
US Classification:
514 19, 514 23, 514 25, 514 53, 514274, 514311, 514422, 514425, 514529, 514547, 514562, 514572, 514574
Abstract:
The invention provides peptides and compounds that can bind to P2Yreceptors that are useful for modulating the secretion of mucus within mucosal surfaces.

Anti-Aging And Wound Healing Compounds

US Patent:
7094754, Aug 22, 2006
Filed:
Aug 15, 2002
Appl. No.:
10/219561
Inventors:
Stephen Quirk - Alpharetta GA, US
Sohail Malik - Roswell GA, US
Julie M. Villanueva - Decatur GA, US
Assignee:
Kimberly-Clark Worldwide, Inc. - Neenah WI
International Classification:
A61K 38/00
US Classification:
514 12
Abstract:
The invention provides inhibitors of matrix metalloproteinases that are useful for encouraging the development of healthy skin and for treating wounds. The inhibitors are peptides having sequences related to cleavage regions of the proenzyme forms of matrix metalloproteinases. The peptide inhibitors of the invention can be formulated into therapeutic compositions, lotions, creams, skin covering and wound dressings that facilitate healing and healthy skin development, discourage scarring and wrinkling and ameliorate the effects of healing.

Indicator Immobilization On Assay Devices

US Patent:
7935538, May 3, 2011
Filed:
Dec 15, 2006
Appl. No.:
11/640100
Inventors:
Xuedong Song - Roswell GA, US
Curtis Sayre - Atlanta GA, US
Shawn R. Feaster - Duluth GA, US
Julie Villanueva - Decatur GA, US
Assignee:
Kimberly-Clark Worldwide, Inc. - Neenah WI
International Classification:
G01N 33/53
US Classification:
436514, 436528, 436810, 435 4, 4352871, 4352887, 435970, 422 50, 422 55, 422 56, 422 681
Abstract:
A lateral flow assay device for detecting the presence or quantity of an analyte in a test sample is provided. The device comprises a chromatographic medium that defines a detection zone, wherein a crosslinked network is non-diffusively immobilized within the detection zone. The crosslinked network contains a small molecule indicator that is configured to undergo a detectable color change in the presence of the analyte.

Wound Or Surgical Dressing

US Patent:
7985209, Jul 26, 2011
Filed:
Dec 15, 2005
Appl. No.:
11/303011
Inventors:
Julie M. Villanueva - Decatur GA, US
Curtis Neil Sayre - Atlanta GA, US
Lei Huang - Duluth GA, US
Kevin Peter McGrath - Alpharetta GA, US
Ning Wei - Roswell GA, US
Assignee:
Kimberly-Clark Worldwide, Inc. - Neenah WI
International Classification:
A61F 13/02
US Classification:
604307, 424682, 424685, 514191
Abstract:
A wound or surgical dressing is disclosed. The wound or surgical dressing is configured to cover or surround a wound, a surgical incision, or any type of skin irritation. In accordance with the present disclosure, the wound or surgical dressing is treated with a bacteriostatic composition that is capable of binding and trapping negatively charged matter, such as bacteria, pathogens, and the like. The bacteriostatic composition comprises a cationic polymer, a cationic oligomer, or particles coated with a cationic material. The bacteriostatic composition is bonded to the wound or surgical dressing in a manner such that the bacteriostatic composition is not substantially transferred to a patient being treated.

Detecting Lipocalin

US Patent:
20040115728, Jun 17, 2004
Filed:
Dec 16, 2002
Appl. No.:
10/320732
Inventors:
Julie Villanueva - Decatur GA, US
Stephen Quirk - Alpharetta GA, US
International Classification:
G01N033/53
G01N033/554
G01N033/569
US Classification:
435/007100
Abstract:
The invention provides antibodies reactive with distinct lipocalin epitopes that are useful for detecting inflammation and bacterial infections in mammals.

Bacteria Removing Wipe

US Patent:
20050137540, Jun 23, 2005
Filed:
Dec 23, 2003
Appl. No.:
10/745266
Inventors:
Julie Villanueva - Decatur GA, US
Curtis Sayre - Atlanta GA, US
Lei Huang - Duluth GA, US
Kevin McGrath - Alpharetta GA, US
Ning Wei - Roswell GA, US
International Classification:
A61F013/15
US Classification:
604360000
Abstract:
There is provided a wipe for the removal of bacteria from surfaces. The wipe has a positive charge that may be developed through the use of cationic treatments. The wipe may be dipped in an aqueous solution of a non-antimicrobial treatment having a positive charge and the excess solution squeezed out of the wipe. Treatment of the resulting coated wipe with heat at a temperature and for a time sufficient adheres the coating to the wipe. Alternatively, a non-antimicrobial, cationically charged chemical may be imbedded in the web such that it will bloom to the surface when the wipe is exposed to water. The web is desirably a pulp and synthetic fiber fabric made by coforming or hydroengling and may be a laminate including other layers. The treated web removes a substantial amount of the bacteria from a surface yet does not appreciably inhibit the growth of the bacteria. The web does not contain harsh chemicals and so is mild in its effect on the user's skin. The removal of the bacteria in contrast to killing the bacteria does not encourage it to develop immunity to the treatment.

Absorption Of Pain-Causing Agents

US Patent:
20050244402, Nov 3, 2005
Filed:
Apr 30, 2004
Appl. No.:
10/835886
Inventors:
Julie Villanueva - Decatur GA, US
Curtis Sayre - Atlanta GA, US
Robert Lyng - Norcross GA, US
International Classification:
A61K039/395
US Classification:
424130100
Abstract:
There is provided a pain relieving substance made of an eicosanoid-absorbent substance and a carrier. The eicosanoid-absorbent substance may be an eicosanoid enzyme, antibody and/or acid moiety binder. The eicosanoids may be prostaglantins, thromboxanes, leukotrienes, lipoxins and hydroxyl and hydroperoxy fatty acids and mixtures thereof. The eicosanoid-absorbent substance may be delivered in a liquid carrier such as a gel or lotion or may be delivered by a solid carrier such as a tampon, sponge, etc.

Bacteria Binding Products

US Patent:
20070134337, Jun 14, 2007
Filed:
Dec 22, 2004
Appl. No.:
10/583423
Inventors:
Julie Villanueva - Decatur GA, US
Curtis Sayre - Atlanta GA, US
Lei Huang - Duluth GA, US
Kevin McGrath - Alpharetta GA, US
Ning Wei - Roswell GA, US
Assignee:
Kimberly-Clark Worldwide, Inc. - Neenah WI
International Classification:
A61K 9/14
C12Q 1/18
B32B 5/02
US Classification:
424489000, 435032000, 977906000, 442123000
Abstract:
There is provided products for the removal of negatively charged particles like bacteria from surfaces. The products have a positive charge that may be developed through the use of cationic treatments. The product or substrate from which it is made may be dipped in an aqueous solution of a non-antimicrobial treatment having a positive charge and the excess solution squeezed out. Treatment of the resulting coated substrate with heat at a temperature and for a time sufficient adheres the coating to the substrate. Alternatively, a non-antimicrobial, cationically charged chemical may be imbedded in a substrate web such that it will bloom to the surface when the web is exposed to water. A suitable substrate web may be a pulp and synthetic fiber fabric made by coforming or hydroengling and may be a laminate including other layers. The treated substrate and product remove a substantial amount of the bacteria from a surface yet do not appreciably kill the bacteria. Harsh, oxidizing, chemicals are not used in the preparation of the products and so the products are mild in their effect on the user's skin. The removal of the bacteria, in contrast to killing the bacteria, does not encourage the bacteria to develop immunity to the treatment.
Julie Annita Villanueva from Roswell, GA, age ~52 Get Report